Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern RNA is an Australian CDMO specializing in the manufacture of high-quality mRNA and plasmid DNA raw materials. The company offers proprietary process technologies such as Co Cap™ A for efficient mRNA synthesis. It provides end-to-end support from construct design through analytical testing, enabling clients’ development of vaccines and advanced therapeutics. Clinical results are not directly reported since the company does not develop its own therapeutic pipeline but supports others’ clinical programs
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southern RNA.